Drugs / Juvederm® ULTRA PLUS XC
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07265791 Comparator | Jan → Jun 2026 overdue | — | Jetema Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Juvederm ULTRA PLUS XC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07265791 ↗ |
| Route | Other | “The product will be injected into the nasolabial folds” NCT07265791 ↗ |